We donated to an organization that conducts international ophthalmology support activities in collaboration with 11 social partners.

Sustainability

Bringing the joy of sight across borders to the world! We are donating to an organization that supports international ophthalmology activities in collaboration with 11 social partners.

May 31, 2023

ROHTO Pharmaceutical Co., Ltd. (Headquarters: Osaka City, President: Masafumi Sugimoto) has donated a portion of the sales of its eye drops to organizations that provide ophthalmic support, such as cataract treatment and diagnosis, in Asia, Africa, and other regions, as part of its efforts to support the "joy of seeing" for people around the world. This initiative began in October 2016 as the first phase of the project, with Rohto and its retail partners working together as "social partners" to engage in social contribution activities that go beyond the boundaries of business.
In the seventh phase, the total amount of support provided was 992,380 yen, which was matched by our company with 496,190 yen, representing a portion of the sales of eye drops (details below) from 11 social partners from December 2022 to March 2023. We are deeply grateful to our social partners and everyone else for their warm support, which has allowed this circle of support to expand.

Report on Support Funds for Social Partner Program, 7th Term (December 1, 2022 - March 31, 2023)​

Donation amounts (11 companies) 496,190円
Matching amount 496,190円
Total waste generated 992,380 yen

Total amount of donations to date

From the first to the seventh phase, we received support from 36 of our business partners, and the total amount donated is 14,612,880 yen.

Donation recipient

OUI Inc. (OUI Corporation) <Representative Director: Eisuke Shimizu>

OUI Inc. is a venture company originating from Keio University School of Medicine, founded by a practicing ophthalmologist. It brings together medical, engineering, and business professionals with the vision of "reducing the global blindness rate by 50% and protecting people's health through eye care." Based on the concept of spreading the ophthalmologist's "eye" to the world, they developed the Smart Eye Camera (SEC), a smartphone-attachable ophthalmic diagnostic device. Using this portable and easy-to-use device, they have been conducting pilot demonstrations utilizing SEC in Vietnam, Cambodia, Indonesia, and Mozambique since 2022, in collaboration with local medical institutions and ophthalmologists.

Amount: 496,190 yen

NPO Asia Association for the Prevention of Blindness <Chairman: Shigeru Kinoshita>

The NPO Asia Blindness Prevention Association was founded in 2003 by a group of volunteers who shared the vision of Dr. Tadashi Hattori, a graduate of the Department of Ophthalmology at Kyoto Prefectural University of Medicine. With the desire to ensure that no one loses their sight in the Indochina Peninsula and other impoverished Asian countries, primarily Vietnam, the association provides free ophthalmic treatment and technical training, as well as material aid such as the provision of ophthalmic medical equipment and supplies. In 2022, particularly in Vietnam where zero-COVID-19 measures were being implemented, the association provided free intraocular lenses and medical technical training in Vinh Phuc and Dac Lac provinces. In addition, the association conducts awareness campaigns such as eye examinations and provides support for arranging treatment for people who cannot afford eye treatment due to poverty in Hanoi, Hue, and Hai Phong.

Amount: 496,190 yen

What is a social partner?

This program involves Rohto Pharmaceutical Co., Ltd. and its retail partners who, in collaboration with the company, donate a portion of their sales to social contribution activities such as medical support in Japan and around the world. For the 7th term, a portion of the sales of "V ROHTO PREMIUM," "V Rohto Active Premium," "V Rohto Dry Eye Premium," and "V Rohto Contact Premium" *1 from December 1, 2022 to March 31, 2023 was donated.

Social Partner Business Partners (in alphabetical order) <7th Term: December 1, 2022 - March 31, 2023>

Akakabe Co., Ltd., Ohga Pharmacy Co., Ltd., Kyorindo Pharmacy Co., Ltd. , Kusuri no Sunroad Co., Ltd., Kokumin Co., Ltd., Sapporo Drug Store Co., Ltd., Shinseido Pharmacy Co., Ltd., Tomod's Co., Ltd., Mine Pharmaceuticals Co., Ltd., Yakuodo Co., Ltd., Yamazawa Pharmaceuticals Co., Ltd.

*1: "V ROHTO PREMIUM" (Category 2 pharmaceutical) for eye strain / "V Rohto Active Premium" (Category 2 pharmaceutical) for eye strain / "V Rohto Dry Eye Premium" (Category 3 pharmaceutical) for dry eyes / "V Rohto Contact Premium" (Category 3 pharmaceutical) for eye strain

Background of the activities

Cataracts are the leading cause of blindness worldwide, and it is estimated that approximately 100 million people are currently blind. Cataracts are a disease in which the lens of the eye, which acts as the eye's lens, becomes cloudy, leading to decreased vision. In Japan, surgical treatment has advanced, and the rate of blindness due to cataracts has become very low. However, globally, in developing countries, many people lose their sight due to cataracts not only because of poverty, but also because of a lack of medical personnel and equipment, resulting in inadequate screenings and diagnoses, and because treatment is not possible due to insufficient surgical techniques.
Our company has previously provided support in various Asian countries, including free eye examinations and treatments, the free provision of intraocular lenses for cataract treatment, and the training of local ophthalmologists. Because we have supported the eye health of people around the world through various activities, including eye drops, we reached out to our business partners with the desire to further expand and continue these activities and provide support to even more people who are on the verge of blindness. As a result, 11 of our business partners have agreed to become "social partners" and collaborate on support activities. We will continue our activities to realize the well-being of people around the world.

Reference Information: Our Overseas Eye Care Initiatives

  • Supporting the Amazon Cataract Eradication Project
    This initiative has been providing continuous support for over 20 years to improve the situation of indigenous communities in Brazil who have difficulty accessing ophthalmic care. Our Brazilian subsidiary, Ophthalmos Rohto, participates as volunteer staff and provides cataract surgery products free of charge, contributing to healthcare that transcends regional and ethnic barriers.
  • Bringing the joy of seeing to the world, beyond national borders! The "Joy of Seeing Project"
    This initiative, launched in 2022 as the "Joy of Seeing (JoS)" project, is a collaboration between our company and overseas Rohto Group affiliates to protect people's eye health worldwide. We started with awareness campaigns and free eye examinations primarily for children in Asia, and in the future, we plan to expand the target area and deliver the "joy of seeing" to people all over the world.